Glycinamide Ribonucleotide Formyltransferase (garft) - Catalysis

Relevant Publications

Dual Template Molecularly Imprinted Polymers Targeting Blockade of CD47 for Enhanced Macrophage Phagocytosis and Synergistic Antimetabolic Therapy.

Issue Release: 2024

Molecular Factors Associated with Pemetrexed Sensitivity According to Histological Type in Non-small Cell Lung Cancer.

Issue Release: 2016

Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.

Issue Release: 2013

Association between expression of thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase and efficacy of pemetrexed in advanced non-small cell lung cancer.

Issue Release: 2012

Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions.

Issue Release: 2012

Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.

Issue Release: 2011

Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.

Issue Release: 2011

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

Issue Release: 2010

The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action.

Issue Release: 2010

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

Issue Release: 2009

Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence.

Issue Release: 2009

5,10-Methenyltetrahydrofolate synthetase activity is increased in tumors and modifies the efficacy of antipurine LY309887.

Issue Release: 2008

New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.

Issue Release: 2008

The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells.

Issue Release: 2007

Derivation and characterization of a monoclonal antibody against human glycinamide ribonucleotide formyltransferase.

Issue Release: 2006

Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis.

Issue Release: 2005

Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.

Issue Release: 2005

Translational research with pemetrexed in breast cancer.

Issue Release: 2004

Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.

Issue Release: 2003

Deaza analogs of folic acid as antitumor agents.

Issue Release: 2003

What is the Mechanism of the Heck Reaction?

What Challenges Exist in Using TiO₂ Nanoparticles?

How to Overcome RBAC Challenges in Catalysis?

How is the Ergun Equation Formulated?

Why is Spectroscopic Data Important in Catalysis?

How is X-ray Diffraction (XRD) utilized in Catalysis?

What Catalysts are Used in DME Production?

What Are the Reporting and Documentation Requirements?

What are the Challenges in Material Screening?

How do Organic Frameworks Function in Catalysis?

Glycinamide Ribonucleotide Formyltransferase (garft) - Catalysis

Relevant Publications

Partnered Content Networks

Relevant Topics